Evaluating CMR

Metabolic Syndrome and Type 2 Diabetes/CVD Risk


Key Points

Page: Go to Previous Page 1 of 9 Go to Next Page

  • WHO was the first major organization to produce a definition of the metabolic syndrome that focused mainly on insulin resistance, whose diagnosis requires an oral glucose tolerance test.
  • WHO criteria also proposed that microalbuminuria as a marker to identify high-risk patients with the metabolic syndrome.
  • In response to WHO, EGIR sought to establish criteria that would be easier to use in clinical practice. EGIR makes measuring insulin resistance mandatory.
  • The AACE position does not provide a specific scoring system for diagnosing the “insulin resistance syndrome”. Insulin resistance is at the core of AACE criteria, while waist circumference is not considered a diagnosis criterion.
  • These organizations acknowledge that their diagnosis tools can be refined and that further research is needed to improve diagnosis of the metabolic syndrome in clinical practice.